Congress locks in NIH funding, blocking executive freeze power
H.R. 2855 — Protecting Medical Research Funding Act · Filed by Timothy Kennedy (D-NY) · 1 cosponsor · Introduced Apr 10, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill prevents the executive branch from freezing, redirecting, or reallocating NIH funding without explicit new legislation. It requires the HHS Secretary to certify annually that NIH funds are being spent as Congress appropriated them, blocking the President from using executive power to withhold or reprogram medical research money.
Why we flagged it
The bill's core function is to shield congressionally appropriated NIH funds from executive impoundment or reprogramming. It is a procedural/governance measure that enforces the separation of powers by preventing the President from unilaterally freezing or redirecting money Congress has already allocated.
What the text implies
- The bill may constrain future executive flexibility in responding to fiscal emergencies or policy shifts, though it preserves Congress's ability to authorize transfers via new legislation.
- The annual certification requirement creates a compliance record that could expose executive non-compliance to congressional oversight and potential legal challenge.
- The bill's reference to the Impoundment Control Act of 1974 suggests it is clarifying or tightening existing law; the full effect depends on how courts have interpreted that Act's scope.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
Citizens benefit from protected medical research funding that Congress has already appropriated. The bill prevents executive withholding of NIH money, ensuring research continuity and protecting the public's investment in biomedical science. The restriction applies only to executive power, not to citizens' rights or remedies.
Who stands to gain
- biomedical research institutions
- pharmaceutical and medical device companies (indirect, via research pipeline)
- academic medical centers and universities
Named in the bill
National Institutes of Health (NIH), Department of Health and Human Services (HHS), House Committee on Energy and Commerce, House Committee on Appropriations, Senate Committee on Appropriations, Senate Committee on Health, Education, Labor and Pensions, Impoundment Control Act of 1974
Where it stands
1 cosponsor: 1 Democrats.
- Apr 10, 2025 — Introduced · Congress.gov: “Introduced in House”
- Apr 10, 2025 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (1,097 characters) on Jun 10, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
As of — page rendered 2026-10-20.
“Congress locks in NIH funding, blocking executive freeze power” QuorumCivic. https://share.quorumcivic.app/bill/119/hr2855 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.